Back to all News & Events >

Our News

WHRI

Immunization of Women with Diphtheria and Tetanus Toxoids Combined with Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate

The purpose of this study is to see if the pertussis (also known as “whooping cough”) vaccine antibodies (protection) are transferred from mother to baby through the placenta and breast milk in high enough levels to provide protection to the newborn baby if the mother receives the pertussis vaccine during the mid third trimester of pregnancy. 

Principal Investigator: Dr. Scott Halperin (Global PI), Dr. Deborah Money (Local PI).

READ MORE
WHRI

A Pilot Study to Determine the Optimal Finger for Hypertension and Preeclampsia Assessment Using Pulse Oximeter Collection

Principal Investigator: Dr. Kenneth I. Lim Primary Contact: Dr. Mohamed Elgendi, Mining for Miracles Postdoctoral Fellow, 604-875-2723 Email: mohamed.elgendi@cw.bc.ca About the study: Hypertensive disorders of pregnancy such as preeclampsia increase the risk of life-ending and life-altering complications for both the mother and her unborn baby. Oxygen levels in pregnant women are measured using a non-invasive […]

READ MORE
WHRI

The Impact of Prenatal Screening for Fetal Aneuploidy on Maternal-Infant Bonding – (Pre-MIB) Study

Principal Investigator: Catriona Hippman Primary Contact: Nicole Prestley, Research Manager, 604-875-2424 ext 4956, Nicole.Prestley@cw.bc.ca About the study: The purpose of this study is to assess how the option to have prenatal genetic screening for chromosome abnormalities can impact maternal-infant bonding during pregnancy. Chromosome abnormalities take place when an abnormal number of chromosomes are within a cell, […]

READ MORE
WHRI

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

The TMIST study will help determine whether tomosynthesis results in fewer false-positive findings (reduced recall rate) than traditional 2D mammography.

Principal Investigator: Dr. Paula Gordon

READ MORE
WHRI

HPV FOCAL Study

A clinical trial conducted within the BC Cervical Cancer Screening Program. HPV FOCAL evaluated the effectiveness and safety of HPV testing compared to the Pap test for cervical cancer prevention.

Principal Investigators: Dr. Gina Ogilvie, Dr. Andrew Coldman

READ MORE
WHRI

Quadrivalent vaccine evaluation study (QUEST)

QUEST (Quadrivalent HPV Vaccine Evaluation Study) is a Canada-wide study designed to evaluate whether 2 doses of the HPV vaccine are just as effective as 3 doses at preventing Human Papillomavirus (HPV) infection and cervical cancer.

Principal Investigators: Drs. Gina Ogilvie, Simon Dobson

READ MORE
WHRI

Long Term Follow-up Study of CTN 236 – A Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women

This study aims to better understand how the HPV vaccine works in HIV positive girls and women over the long term and to clarify how care can be provided to best protect this population from HPV infection and associated cervical cancer and genital warts.

Principal Investigator: Dr. Deborah Money

READ MORE
WHRI

CARMA-1-PREG

CARMA-1-PREG is investigating factors related to pre-term deliveries among HIV positive women.

Principal Investigator: Dr. Deborah Money

READ MORE
WHRI

CARMA 7: Bone and Renal Outcomes in HIV-Exposed, Uninfected Infants with Perinatal Exposure to Tenofovir

The purpose of CARMA 7 is to investigate how fetal exposure to the anti-HIV medication Tenofovir may affect the bone and kidney health of infants who are born to HIV+ women.

Principle Investigator: Dr. Ariane Alimenti

READ MORE
Top
WHRI Menu
WHRI Menu